ERBB2 and breast cancer: Third, subgroup analysis according to the molecular subtypes suggested that the prognostic significance of TSR in the HER2-positive breast cancer, TNBC, and luminal-HER2-negative breast cancer subgroups did not differ from the prognostic value in the total breast cancer series.